<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Migraine: Developing Drugs for Acute Treatment; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Migraine: Developing Drugs for Acute Treatment; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2018-02-16 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a guidance for industry entitled "Migraine: Developing Drugs for Acute Treatment." The purpose of this guidance is to assist sponsors in the clinical development of prescription drugs for the acute treatment of migraine. This guidance focuses on specific drug development and trial design issues that are unique to the study of prescription drugs for the acute treatment of migraine. This guidance finalizes the draft...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2018-03224</p>
    <p><strong>Publication Date:</strong> 2018-02-16</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2018/02/16/2018-03224/migraine-developing-drugs-for-acute-treatment-guidance-for-industry-availability">https://www.federalregister.gov/documents/2018/02/16/2018-03224/migraine-developing-drugs-for-acute-treatment-guidance-for-industry-availability</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2018-03224</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
